Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment-resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma.
S. M. Iqbal, Kathryn Stecklein, Joseph L. Sarow, M. Krabak +2 more
2019Clinical Lymphoma, Myeloma & Leukemia22 citations
Semantic Scholar

